Kristin Wannerberger
Ferring Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kristin Wannerberger.
Journal of Crohns & Colitis | 2017
Matthieu Galtier; Luisa De Sordi; Adeline Sivignon; Amélie de Vallée; Damien Maura; Christel Neut; Oumaira Rahmouni; Kristin Wannerberger; Arlette Darfeuille-Michaud; Pierre Desreumaux; Nicolas Barnich; Laurent Debarbieux
Background and Aims Adherent invasive Escherichia coli [AIEC] are abnormally predominant on the ileal mucosa of Crohns disease [CD] patients. They bind to the CEACAM6 receptor expressed on the surface of epithelial cells. We aimed to assess the potential of bacteriophages, viruses infecting bacteria, to decrease the levels of AIEC bacteria associated with the intestinal mucosa. Methods We combined ex vivo and in vivo experiments with murine and human intestinal samples to quantify the ability of virulent bacteriophages to target the prototype AIEC strain LF82. Results We found that three virulent bacteriophages were able to replicate in ileal, caecal and colonic sections and faeces homogenates from murine gut samples colonised with the prototype AIEC strain LF82. A single day of per os treatment with the three bacteriophages cocktail given to LF82-colonised CEABAC10 transgenic mice, expressing the human CEACAM6 receptor for AIEC, decreased significantly the number of AIEC in faeces and in the adherent flora of intestinal sections. In addition, a single dose of the cocktail reduced dextran sodium sulphate-induced colitis symptoms on conventional mice colonised with the strain LF82 over a 2-week period. The cocktail targeted also LF82 bacteria in homogenates of ileal biopsies taken from CD patients. Conclusions These findings demonstrate that bacteriophages are a new treatment option for targeting AIEC in CD patients and represent a strong basis for a clinical trial evaluation.
Scientific Reports | 2017
Javier Sotres; Skaidre Jankovskaja; Kristin Wannerberger; Thomas Arnebrant
Mucus is the viscous gel that protects mucosal surfaces. It also plays a crucial role in several diseases as well as in mucosal drug delivery. Because of technical limitations, mucus properties have mainly been addressed by in-vitro studies. However, this approach can lead to artifacts as mucus collection can alter its structure. Here we show that by using an implemented atomic force microscope it is possible to measure the interactions between micro-particles and mucus blankets ex-vivo i.e., on fresh excised mucus-covered tissues. By applying this method to study the small intestine, we were able to quantify the stiffness and adhesiveness of its mucus blanket at different pH values. We also demonstrate the ability of mucus blankets to bind and attract particles hundreds of µm away from their surface, and to trap and bury them even if their size is as big as 15 µm.
Archive | 2003
Kristin Wannerberger; Hans Lindner; Lars-Erik Olsson; Ann Elisabeth Svensson
Archive | 2004
Kristin Wannerberger; Lars Anders Ragnar Nilsson
Archive | 2011
Shweta Gupta; Varinder Ahuja; Tejas Gunjikar; Kristin Wannerberger
Archive | 2003
Kristin Wannerberger; Lars Anders Ragnar Nilsson
Archive | 2013
Varinder Ahuja; Rajan Verma; Umesh Vinayakrao Barabde; Arne Hagsten; Kristin Wannerberger; Rambabu Boorugu; Amol Vilasrao Somwanshi
Archive | 2017
Amol Vilasrao Somwanshi; Arne Hagsten; Kristin Wannerberger; Rajan Verma; Rambabu Boorugu; Umesh Vinayakrao Barabde; Varinder Ahuja
Archive | 2015
Varinder Ahuja; Rajan Verma; Umesh Vinayakrao Barabde; Arne Hagsten; Kristin Wannerberger; Rambabu Boorugu; Amol Vilasrao Somwanshi
Archive | 2011
Varinder Ahuja; Tejas Gunjikar; Kristin Wannerberger